Hans Hekland - 01 Jan 2026 Form 3 Insider Report for MAINZ BIOMED N.V. (MYNZ)

Reporting relationship: Director
Issuer ticker: MYNZ
Reported as of: 01 Jan 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 19 Feb 2026, 17:09:16 UTC
Source filing: View source filing
Reporting owner signature: /s/ Hans Hekland

Key filing fact

Hans Hekland filed Form 3 for MAINZ BIOMED N.V. (MYNZ) on 19 Feb 2026.

Key facts

This page summarizes Hans Hekland's Form 3 filing for MAINZ BIOMED N.V. (MYNZ).
0 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 19 Feb 2026, 17:09.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001923690 Primary reporting owner

Hekland Hans

Relationship: Director
Address: MAINZ BIOMED N.V., ROBERT KOCH STRASSE 50, MAINZ
Signature: /s/ Hans Hekland
Signature date: 19 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MYNZ holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 45,000
Date: 01 Jan 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MYNZ holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jan 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 10,000
Exercise price: $4.95
Footnotes: F1

MYNZ holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jan 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 125
Exercise price: $580.00
Footnotes: F2

MYNZ holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jan 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 625
Exercise price: $200.00
Footnotes: F2

MYNZ holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jan 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 250
Exercise price: $302.80
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

50% of the option vested upon grant on 03/04/2025; the remaining balance vests 25% on 03/24/26 and 25% on 03/04/2027.

Footnote F2

Fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .